Literature DB >> 10568171

Subcellular localization patterns and their relationship to photodynamic activity of pyropheophorbide-a derivatives.

I J MacDonald1, J Morgan, D A Bellnier, G M Paszkiewicz, J E Whitaker, D J Litchfield, T J Dougherty.   

Abstract

To determine if subcellular localization is important to photodynamic therapy (PDT) efficacy, an in vitro fluorescence microscopy study was conducted with a congeneric series of pyropheophorbide-a derivatives in human pharyngeal squamous cell carcinoma (FaDu) cells and murine radiation-induced fibrosarcoma (RIF) mutant cells. In the FaDu cells the octyl, decyl and dodecyl ether derivatives localized to the lysosomes at extracellular concentrations less than needed to produce a 50% cell kill (LD50). At extracellular concentrations equal or greater than the LD50 the compounds localized mainly to mitochondria. The propyl, pentyl, hexyl and heptyl ether derivatives localized mainly to the mitochondria at all concentrations studied. This suggested that mitochondria are a sensitive PDT target for these derivatives. Similar experiments were performed with two Photofrin-PDT resistant RIF cell lines, one of which was found to be resistant to hexyl ether derivative (C6) mediated-PDT and the other sensitive to C6-PDT relative to the parent line. At extracellular concentrations of C6 below the LD50 of each cell line, the mutants exhibited lysosomal localization. At concentrations above these values the patterns shifted to a mainly mitochondrial pattern. In these cell lines mitochondrial localization also correlated with PDT sensitivity. Localization to mitochondria or lysosomes appeared to be affected by the aggregation state of the congeners, all of which are highly aggregated in aqueous medium. Monomers apparently were the active fraction of these compounds because equalizing the extracellular monomer concentrations produced equivalent intracellular concentrations, photoxicity and localization patterns. Compounds that were mainly aggregates localized to the lysosomes where they were rendered less active. Mitochondria appear to be a sensitive target for pyropheophorbide-a-mediated photodamage, and the degree of aggregation seems to be a determinant of the localization site.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10568171

Source DB:  PubMed          Journal:  Photochem Photobiol        ISSN: 0031-8655            Impact factor:   3.421


  26 in total

Review 1.  Structural and physico-chemical determinants of the interactions of macrocyclic photosensitizers with cells.

Authors:  Halina Mojzisova; Stéphanie Bonneau; Daniel Brault
Journal:  Eur Biophys J       Date:  2007-07-13       Impact factor: 1.733

2.  Imidazole metalloporphyrins as photosensitizers for photodynamic therapy: role of molecular charge, central metal and hydroxyl radical production.

Authors:  Pawel Mroz; Jayeeta Bhaumik; Dilek K Dogutan; Zarmeneh Aly; Zahra Kamal; Laiqua Khalid; Hooi Ling Kee; David F Bocian; Dewey Holten; Jonathan S Lindsey; Michael R Hamblin
Journal:  Cancer Lett       Date:  2009-04-05       Impact factor: 8.679

3.  Synthesis and evaluation of cationic bacteriochlorin amphiphiles with effective in vitro photodynamic activity against cancer cells at low nanomolar concentration.

Authors:  Sulbha K Sharma; Michael Krayer; Felipe F Sperandio; Liyi Huang; Ying-Ying Huang; Dewey Holten; Jonathan S Lindsey; Michael R Hamblin
Journal:  J Porphyr Phthalocyanines       Date:  2013-01       Impact factor: 1.811

4.  In vitro photodynamic therapy and quantitative structure-activity relationship studies with stable synthetic near-infrared-absorbing bacteriochlorin photosensitizers.

Authors:  Ying-Ying Huang; Pawel Mroz; Timur Zhiyentayev; Sulbha K Sharma; Thiagarajan Balasubramanian; Christian Ruzié; Michael Krayer; Dazhong Fan; K Eszter Borbas; Eunkyung Yang; Hooi Ling Kee; Christine Kirmaier; James R Diers; David F Bocian; Dewey Holten; Jonathan S Lindsey; Michael R Hamblin
Journal:  J Med Chem       Date:  2010-05-27       Impact factor: 7.446

5.  Core-based lipid nanoparticles as a nanoplatform for delivery of near-infrared fluorescent imaging agents.

Authors:  Nadia Anikeeva; Yuri Sykulev; Edward J Delikatny; Anatoliy V Popov
Journal:  Am J Nucl Med Mol Imaging       Date:  2014-09-06

6.  Photosensitizer fluorescence and singlet oxygen luminescence as dosimetric predictors of topical 5-aminolevulinic acid photodynamic therapy induced clinical erythema.

Authors:  Srivalleesha Mallidi; Sriram Anbil; Seonkyung Lee; Dieter Manstein; Stefan Elrington; Garuna Kositratna; David Schoenfeld; Brian Pogue; Steven J Davis; Tayyaba Hasan
Journal:  J Biomed Opt       Date:  2014-02       Impact factor: 3.170

7.  Mechanisms in photodynamic therapy: part one-photosensitizers, photochemistry and cellular localization.

Authors:  Ana P Castano; Tatiana N Demidova; Michael R Hamblin
Journal:  Photodiagnosis Photodyn Ther       Date:  2004-12       Impact factor: 3.631

8.  The effect of photodynamic therapy on tumor cell expression of major histocompatibility complex (MHC) class I and MHC class I-related molecules.

Authors:  Alan Belicha-Villanueva; Jonah Riddell; Naveen Bangia; Sandra O Gollnick
Journal:  Lasers Surg Med       Date:  2012-01-03       Impact factor: 4.025

9.  Catch and Release Photosensitizers: Combining Dual-Action Ruthenium Complexes with Protease Inactivation for Targeting Invasive Cancers.

Authors:  Karan Arora; Mackenzie Herroon; Malik H Al-Afyouni; Nicholas P Toupin; Thomas N Rohrabaugh; Lauren M Loftus; Izabela Podgorski; Claudia Turro; Jeremy J Kodanko
Journal:  J Am Chem Soc       Date:  2018-10-22       Impact factor: 15.419

10.  A fiberoptic (photodynamic therapy type) device with a photosensitizer and singlet oxygen delivery probe tip for ovarian cancer cell killing.

Authors:  Dorota Bartusik; David Aebisher; Ashwini Ghogare; Goutam Ghosh; Inna Abramova; Tayyaba Hasan; Alexander Greer
Journal:  Photochem Photobiol       Date:  2013-04-22       Impact factor: 3.421

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.